Skip to main content
Clinical Trials/NCT05304728
NCT05304728
Enrolling By Invitation
Not Applicable

Sepsis Onset Warning System [SOWS] Master Enrollment Study Protocol

Beckman Coulter, Inc.10 sites in 1 country40,000 target enrollmentFebruary 15, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Severe Sepsis
Sponsor
Beckman Coulter, Inc.
Enrollment
40000
Locations
10
Primary Endpoint
Severe Sepsis
Status
Enrolling By Invitation
Last Updated
last year

Overview

Brief Summary

This protocol will collect real-world data retrospectively from the electronic health record (EHR) as data obtained from the delivery of routine medical care to develop a machine learning (ML)-based Clinical Decision Support (CDS) system for severe sepsis prediction and detection.

Detailed Description

The purpose of this study is to gather data for the clinical development of the Sepsis Onset Warning System (SOWS) Software as Medical Device (SaMD) product to support a De Novo FDA submission and commercialization in the United States. Product development of SOWS is funded in part with federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority. Data will be obtained from passive prospective collection of patient encounter data throughout the duration of the planned study to support the product development life cycle activities associated with developing the Sepsis Onset Warning System (SOWS) for severe sepsis risk detection. Inputs from patient health records in combination with proprietary hematology parameters developed by Beckman Coulter, such as Monocyte Distribution Width (MDW), will be used. The SOWS tool will look to use clinical measurements which are commonly and reliably available in the EHR as structured data elements, such as heart rate, temperature, blood pressure, and laboratory results and account for changes in these values over time.

Registry
clinicaltrials.gov
Start Date
February 15, 2021
End Date
December 31, 2026
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All races, ages and ethnicities
  • All patients admitted to the hospital or presenting to the Emergency Department

Exclusion Criteria

  • Patients not presenting to a hospital setting (e.g. urgent care, outpatient clinic excluded).

Outcomes

Primary Outcomes

Severe Sepsis

Time Frame: Within 6 hours from presentation to the emergency department

Identify patients having Severe Sepsis with the use of electronic health data

Secondary Outcomes

  • Mortality(Within 6hours from presentation to the emergency department)
  • Length of Stay(Within 6hours from presentation to the emergency department)
  • Re-admission Rates(Within 6hours from presentation to the emergency department)

Study Sites (10)

Loading locations...

Similar Trials